Circulating human papillomavirus type 16 specific T‐cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts
- 27 August 2007
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 121 (12) , 2711-2715
Abstract
Human papillomavirus (HPV) is a necessary factor in the pathogenesis of cervical cancer. Circulating HPV‐specific T‐cells responding to the E6 and E7 HPV proteins can be detected only in half of cervical cancer patients. Potential explanations for the absence of this response are lack of sufficient amounts of antigen to activate the immune response or local immune escape mechanisms. We studied the relationship between HPV 16 E6/E7 oncogene mRNA expression, human leukocyte antigen (HLA) expression on tumor cells and the presence of circulating E6‐ and E7‐specific T‐cell responses in cervical cancer patients. The amount of antigen was assessed by HPV E6/E7 mRNA expression levels measured by quantitative polymerase chain reaction. HLA Class I and Class II expression on tumor cells was analyzed by immunohistochemistry. A proliferative HPV‐specific T‐cell response was detected in 15/29 patients. The amount of HPV E6/E7 mRNA was not related to the presence of immune response. HLA Class I expression was downregulated in 19 patients and completely lost in 7 patients. HLA Class II expression was upregulated in 18 patients. HLA Class I expression on tumor cells showed a strong correlation with immunity (p = 0.001). Explicitly, all patients with complete HLA loss lacked HPV specific T‐cell responses. The presence of circulating HPV‐specific T‐cells might reflect ongoing antitumor response that is sustained by CD8+ T‐cells killing HLA Class I positive cancer cells. We hypothesize that HLA Class I expression status on tumor cells might as well influence the response to HPV E6/E7 directed immunotherapy.Keywords
This publication has 30 references indexed in Scilit:
- High Human Papillomavirus Oncogene mRNA Expression and Not Viral DNA Load Is Associated with Poor Prognosis in Cervical Cancer PatientsClinical Cancer Research, 2007
- High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical CancerCancer Research, 2007
- Frequent HLA Class I Loss is an Early Event in Cervical CarcinogenesisHuman Immunology, 2005
- High‐resolution multi‐parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin‐embedded tissuesThe Journal of Pathology, 2005
- Magnitude and polarization of P53‐specific T‐helper immunity in connection to leukocyte infiltration of colorectal tumorsInternational Journal of Cancer, 2003
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related componentsEuropean Journal of Cancer, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- HLA control in the progression of human papillomavirus infectionsSeminars in Cancer Biology, 1996
- T Cell Proliferative Responses Against Human Papillomavirus Type 16 E7 Oncoprotein are Most Prominent in Cervical Intraepithelial Neoplasia Patients with a Persistent Viral InfectionJournal of General Virology, 1996